Nomura Holdings’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-13,434
| Closed | -$1.83M | – | 1398 |
|
2024
Q4 | $1.83M | Buy |
+13,434
| New | +$1.83M | ﹤0.01% | 637 |
|
2024
Q3 | – | Sell |
-1,700
| Closed | -$234K | – | 1193 |
|
2024
Q2 | $234K | Buy |
+1,700
| New | +$234K | ﹤0.01% | 929 |
|
2022
Q4 | – | Sell |
-9,000
| Closed | -$956K | – | 1152 |
|
2022
Q3 | $956K | Buy |
+9,000
| New | +$956K | ﹤0.01% | 595 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 1568 |
|
2022
Q1 | – | Sell |
-4,500
| Closed | -$383K | – | 1706 |
|
2021
Q4 | $383K | Buy |
+4,500
| New | +$383K | ﹤0.01% | 1147 |
|
2021
Q2 | – | Sell |
-12,000
| Closed | -$1.17M | – | 1768 |
|
2021
Q1 | $1.17M | Buy |
+12,000
| New | +$1.17M | ﹤0.01% | 708 |
|
2020
Q4 | – | Sell |
-38,000
| Closed | -$3.65M | – | 1183 |
|
2020
Q3 | $3.65M | Buy |
+38,000
| New | +$3.65M | 0.01% | 327 |
|
2020
Q2 | – | Sell |
-8,771
| Closed | -$761K | – | 901 |
|
2020
Q1 | $761K | Buy |
8,771
+218
| +3% | +$18.9K | ﹤0.01% | 355 |
|
2019
Q4 | $919K | Sell |
8,553
-21,947
| -72% | -$2.36M | ﹤0.01% | 483 |
|
2019
Q3 | $2.73M | Buy |
30,500
+27,000
| +771% | +$2.41M | 0.01% | 318 |
|
2019
Q2 | $297K | Sell |
3,500
-54,168
| -94% | -$4.6M | ﹤0.01% | 636 |
|
2019
Q1 | $5.12M | Sell |
57,668
-7,998
| -12% | -$710K | 0.02% | 273 |
|
2018
Q4 | $4.68M | Buy |
65,666
+9,479
| +17% | +$675K | 0.02% | 309 |
|
2018
Q3 | $6.99M | Buy |
56,187
+17,148
| +44% | +$2.13M | 0.02% | 238 |
|
2018
Q2 | $3.84M | Sell |
39,039
-2,243
| -5% | -$220K | 0.01% | 333 |
|
2018
Q1 | $3.42K | Buy |
41,282
+25,400
| +160% | +$2.11K | 0.01% | 397 |
|
2017
Q4 | $1.23M | Sell |
15,882
-16,000
| -50% | -$1.24M | ﹤0.01% | 605 |
|
2017
Q3 | $1.95M | Buy |
31,882
+21,750
| +215% | +$1.33M | ﹤0.01% | 475 |
|
2017
Q2 | $466K | Buy |
+10,132
| New | +$466K | ﹤0.01% | 855 |
|
2017
Q1 | – | Sell |
-9,031
| Closed | -$350K | – | 1005 |
|
2016
Q4 | $350K | Sell |
9,031
-39
| -0.4% | -$1.51K | ﹤0.01% | 831 |
|
2016
Q3 | $461K | Buy |
+9,070
| New | +$461K | ﹤0.01% | 498 |
|
2013
Q3 | – | Sell |
-50,400
| Closed | -$672K | – | 2405 |
|
2013
Q2 | $672K | Buy |
+50,400
| New | +$672K | 0.01% | 1079 |
|